contract award set stage
multipl re-rat upgrad
ow
unit aetna decis open lab contract
establish long-term strateg partnership
lh set stage ration price share gain
opportun posit lab rel safe haven
within hc servic sector upgrad share ow
contract overhang remov pave way stabl price
environ labcorp simultan announc
establish long term strateg partnership labcorp
subsequ announc firm relationship aetna provid closur
contract overhang signal disciplin price environ
forseeabl futur new valu base program includ agreement
unit offer addit price upsid option time
increas confid quest diagnost deliv earn growth
high end long-term goal januari quest
diagnost becom in-network provid unit member open
opportun expand share current estim
nation share expect quest capit opportun
two three year period translat increment bp volum per year
first year repric exist unit
busi translat bp price headwind
estim see exhibit price comp normal year two
appreci support
institut investor all-america
request ballot
 distribut unit state america
unless otherwis note metric base modelwar
base consensu methodolog
consensu data provid thomson reuter estim
updat estim new estim reflect benefit unitedhealth
volum partial off-set lower price lost aetna volum
model revenu million million ep
prior model revenu million
million ep estim higher
manag guidanc least earn
rais price target dcf deriv price target wacc
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
termin growth impli target multipl earn
impli multipl premium pre-announce level
think improv outlook stabl backdrop reward multipl
expans in-lin past period see exhibit moreov among broader
health care servic peer group constrain price regulatori
uncertainti lab offer visibl around medicar rate cut evid
catalyst manag expect provid guidanc financi
impact contract novemb investor day
stabil price share gain opportun set stage multipl expans
stabil price share gain opportun set stage multipl expans
deriv dcf termin growth wacc
impli price-to-earnings bull case ep
impli price-to-earnings bull case ep
top-line growth mid-term growth
contract drive increas volum includ off-set
aetna volum loss price bp ep growth
benefit capit deploy manag guidanc
mid high singl digit earn growth termin growth rate
impli price-to-earnings base case ep
impli price-to-earnings base case ep
top-line growth mid-term growth
contract drive increas volum includ off-set
aetna volum loss flat price ep growth
benefit capit deploy in-line manag guidanc
mid high singl digit earn growth termin growth rate
impli price-to-earnings bear case ep
impli price-to-earnings bear case ep
top-line growth mid-term growth
volum off-set price eros increas volum
includ off-set aetna volum loss price bp
ep growth manag guidanc mid high
singl digit earn growth termin growth rate
largest nation
lab market share
unit decis open lab contract
establish long-term strateg
partnership two nation lab quest
diagnost labcorp set stage
ration price provid quest
opportun gain market share
capit deploy form tuck-in
cost cut program invigor
molecular diagnost supplement
ep estim higher
manag guidanc least
earn
outcom pama litig
risk achiev price
volum growth share gain meet
save program magnitud come
expect
commit price
assum follow
base element contract
also provid opportun
financi incent
enhanc econom
relationship mark guinan
unit aetna contract announc mark new era lab year
exclus histor context underscor signific unit aetna
decis open lab contract labcorp
last year lab industri experienc two contract cycl
spearhead move transit manag care
relationship low price capit contract fee servic arrang
result industri benefit higher price translat margin
expans rate multipl see exhibit period
lh share respect outperform market
labcorp sign exclus servic contract unit see
aetna follow less year later enter
exclus contract see initi fear land grab never fulli
materi struggl year regain leadership
posit wherea labcorp diversifi busi acquir covanc cro
busi fuel growth
last week announc unit aetna open contract
nation partner set path two nation lab return
disciplin price mind-set commit manag team
exhibit new lab contract opportun multipl re-rat period case
unit contract blueprint value-bas contract provid upsid option
unit partnership labcorp establish new value-bas
program provid upsid price option lab time conting upon
success move volum out-of-network hospit outpati lab high
cost in-network lab lower-cost altern deliv improv patient
experi data share goal contract first kind quest
diagnost labcorp deploy capit last two year
improv digit connect patient upgrad servic center build
exist data analyt asset establish key retail partnership
safeway creat infrastructur support valu base type agreement
guardrail intact put proof concept hand lab base
convers unit understand immedi remov
guardrail direct volum labcorp onu
nation provid proactiv reach local physician offer
tailor servic market consum -friendli offer gain share
market latest develop includ use data extend care
servic attract provid payer alik success time
reach mileston within contract could translat higher revenu captur
requisit also known price
regulatori risk pama rate cut larg understood factor estim
fourth quarter key overhang lab share medicar
reimburs rate cut longer term impact earn power context
center medicar medicaid launch data collect period
compar medicar reimburs commerci market subsequ enact
market-bas price schedul lower overal medicar reimburs begin
put pressur lab provid top-line margin profit final
clf clinic lab fee schedul novemb enact reimburs
rate cut per year period three year start januari thru
medicar account revenu reimburs
cut translat bp headwind price step bp
headwind deliv annual cost cut million key
manag off-set rate cut
take consider data collect data report payment rate
schedul updat everi year encourag lab behav
disciplin manner creat price floor reimburs rate
recalcul set lab apart health care servic sector broadli
constrain price regulatori concern govern polici decis
weigh heavili drug suppli chain stock sinc presidenti elect
drug price spotlight pama decis rearview mirror lab
emerg rel safe haven view offer clear visibl around medicar
rate cut deliv path forward incorpor price disciplin commerci
part busi
quantifi impact financi
pama rate set factor estim guidanc visibl increment
headwind horizon limit regulatori risk enhanc visibl price
disciplin increas confid manag abil execut
consumer-orient strategi share perform execut
long-term top-line high middl singl earn guidanc rang
tuck acquisit supplement growth profil quest diagnost multi-
prong growth strategi focus expand relationship hospit
get closer patients/consum via retail partnership organ growth
hover normal weather holiday
averag tuck acquisit on-going cost
cut initi supplement organ growth help off-set headwind
unit contract provid volum opportun somewhat off-set price quest
diagnost in- network provid unit million insur custom
start januari major under- index quest today
look quest current unit exposur exist statu prior new agreement
bisect custom two categori in- network expect averag
price remain constant network particip estim
unit volum estim quest current process portion
volum higher network rate term new agreement quest
diagnost becom network lab unit full membership estim
compani increas share nation level gain share
year exchang believ see price step-down
current network share assum drop price translat
bp price headwind year one contract exhibit
aetna open network agreement labcorp caus share loss quest
diagnost labcorp also in-network provid aetna million insur
custom start januari howev lose statu
sole nation in-network lab expect compani share aetna book
declin estim today nation averag market share
net-net expect two network chang drive increment
volum tailwind next two year bp price headwind
revis estim account increas volum partial off-set lower price
model revenu vs prior
respect consensu
compar guidanc million note estim
assum volum growth flat price
model ep vs prior
respect consensu compar guidanc
manag mid term guidanc least earn
rais price target upgrad rate overweight
equal-weight dcf deriv price target assum wacc
termin growth rate impli price-to-earnings multipl
respect see opportun multipl re-rat benefit greater
visibl rel price stabil share gain stabl top-line oper incom
growth mid-singl digit bull case valuat bear case
thomson reuter compani data morgan stanley research estim valuat methodolog risk associ price target referenc research report pleas contact client support follow us/canada hong kong latin america
london singapor sydney tokyo altern may contact invest repres morgan stanley research broadway attent research manag new york ny usa stock rate price target estim
compani remov consider report applic law and/or polici may preclud issu inform respect compani time
lh ow pt dcf deriv pt assum wacc
perpetu growth rate bull case valuat bear case risk
price target includ volum rebound reimburs pressur may
greater expect covanc chiltern deal synergi materi
impact pama price greater expect unabl execut
